February 2026
The global cardiovascular genetic testing market size was evaluated at USD 11.34 billion in 2025 and is predicted to hit around USD 33.38 billion by 2035, growing at a CAGR of 11.4%.
September 2026
The global genetic testing market size is calculated at USD 27.32 billion in 2026 and is projected to hit around USD 71.09 billion by 2035 with a soild CAGR of 11.26%.
September 2026
The global genetic toxicology testing market size was evaluated at USD 2.49 billion in 2026 and is predicted to hit around USD 5.97 billion by 2035, growing at a CAGR of 10.20%.
August 2026
The direct-to-consumer genetic testing market reached USD 2.45 billion in 2026, featuring leading direct-to-consumer genetic testing companies such as Identigene, Karmagenes, Living DNA, Mapmygenome.
June 2026
The global prenatal and newborn genetic testing market size is projected to hit around USD 30.94 billion by 2035, increasing from USD 10.48 billion in 2026, with at a solid CAGR of 12.8%.
June 2025
The consumer genomics market size was valued at USD 2.03 billion in 2024 and it is expected hit around USD 18.83 billion by 2034 with a CAGR of 24.95%.
September 2026
The global endotoxin testing market size is expected to increase from USD 1.60 billion in 2026 to hit around USD 3.78 billion by 2035, growing at a CAGR of 10.05%.
September 2026
The global diagnostic testing market size reached USD 213.03 billion in 2026 and is projected to hit around USD 281.56 billion by 2035, growing at a CAGR of 3.08%.
September 2026
The global esoteric testing market size is estimated at USD 41.05 billion in 2026 and is predicted to hit around USD 100.94 billion by 2035 with a CAGR of 10.53%.
September 2026
The global cardiovascular ultrasound market size reached USD 3.20 billion in 2026 and is projected to surpass around USD 5.61 billion by 2035 with a CAGR of 6.42%.
September 2026
The global cardiovascular drugs market size is valued at USD 162.02 billion in 2026 and is expected to hit around USD 221.20 billion by 2035, growing at a CAGR of 3.56% from 2026 to 2035.
September 2026
The global cardiovascular devices market size is expected to increase from USD 80.61 billion in 2026 to hit around USD 158.41 billion by 2035, with a CAGR of 7.81%.
September 2026
The cardiovascular digital solutions market size is expected to hit around USD 212.53 billion by 2035 from USD 135.10 billion in 2026 with a CAGR of 5.17%.
September 2026
The global endocrine testing market size was estimated at USD 16.97 billion in 2026 and is expected to surge around USD 35.43 billion by 2035 with a CAGR of 8.53%
September 2026
The non-invasive prenatal testing market size was USD 8.05 billion in 2026, with leading non-invasive prenatal testing market players including Genesis Genetics, Natera, Centogene, Eurofins LifeCodexx GmbH.
September 2026
The global toxicology testing services market size is estimated to surpass around USD 70.78 billion by 2035 from USD 43.55 billion in 2026, with a CAGR of 5.55%.
September 2026
The non-destructive testing (NDT) market size accounted for USD 24.59 billion in 2025 and is expected to hit around USD 56.23 billion by 2035 with a CAGR of 9.69%.
September 2026
The global noise vibration and harshness testing market size is estimated to hit around USD 4.62 billion by 2034 increasing from USD 2.84 billion in 2026, at a CAGR of 6.30%.
September 2026
The global bacteriological testing market size was evaluated at USD 28.02 billion in 2026 and is predicted to hit around USD 54.35 billion by 2035, growing at a CAGR of 7.64%.
September 2026
The global microbiology testing market size reached USD 6.88 billion in 2026 and is projected to be worth around USD 14.74 billion by 2035 with a CAGR of 8.85%.
September 2026
The global generative AI in testing market size was evaluated at USD 73.19 million in 2026 and is predicted to hit around USD 439.81 million by 2035, growing at a CAGR of 22.05%.
September 2026
The rapid microbiology testing market size was USD 4.07 billion in 2026, with leading rapid microbiology testing market players including Accelerate Diagnostics, Inc., Becton, Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories, Inc.
September 2026
The rapid microbiology testing market size was USD 7.37 billion in 2026, with leading rapid microbiology testing market players including Creative Diagnostics, bioMérieux, Synbiosis, Thermo Fisher Scientific,
September 2026
The global 5G testing market size is projected to surpass around USD 8.39 billion by 2034, increasing from USD 4.46 billion in 2026, with a solid CAGR of 8.22%.
September 2026
The global automation testing market size was estimated at USD 48.88 billion in 2026 and is predicted to reach around USD 169.33 billion by 2034 with a CAGR of 16.90%.
September 2026
The biological safety testing market size was evaluated at USD 6.26 billion in 2026 and is predicted to surpass around USD 17.00 billion by 2034, with a CAGR of 13.36%.
September 2026
The global cardiovascular clinical trials market size was valued at USD 6.68 billion in 2026 and is expected to hit around USD 10.62 billion by 2034, growing at a CAGR of 5.98%.
September 2026
The global animal genetics market size was estimated at USD 7.36 billion in 2026 and is expected to hit around USD 12.67 billion by 2035, growing at a CAGR of 6.23%.
September 2026
The genetically modified feed market size was valued at USD 112.17 billion in 2026 and is expected to hit around USD 171.76 billion by 2034, growing at a CAGR of 5.48%.
September 2026
The epigenetics diagnostics market size was evaluated at USD 22.40 billion in 2026 and is predicted to worth around USD 67.26 billion by 2034, with a CAGR of 14.81%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com